Copaxone 20 mg in 1 mL Prefilled Syringe
RxNorm 1111642
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1111642 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Copaxone 20 mg in 1 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
1 mL Copaxone 20 mg/ML Prefilled Syringe
(Atom ID: 2774546)
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL glatiramer acetate 20 mg/ML Prefilled Syringe [Copaxone]
(Atom ID: 3718336)
PSNPrescribable
Prescribable Name (PSN):
Copaxone 20 mg in 1 mL Prefilled Syringe
(Atom ID: 6839855)
SYPrescribable
Synonym (SY):
Copaxone 20 mg per 1 mL Prefilled Syringe
(Atom ID: 3718337)
Patient Education
Glatiramer Injection
Glatiramer injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Glatiramer is in a class of medications called immunomodulators. It works by stopping the body from damaging its own nerve cells (myelin).
[Learn More]
* Please review the disclaimer below.